









Yaletown Capital Corp. Grants Stock Options


🞛 This publication is a summary or evaluation of another publication
May 09, 2012 15:08 ET
Yaletown Capital Corp. Grants Stock Options
VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 9, 2012) -Yaletown Capital Corp. (the "Company") (TSX VENTURE:YCC) announces that, subject to regulatory approval, it has granted under its 2012 Incentive Stock Option Plan a total of 300,000 incentive stock options to certain directors at a price of $0.18 per share, exercisable for a period of 5 years.
On Behalf of the Board of Directors
Douglas Kind, President and C.E.O.
About Yaletown Capital Corporation and its wholly owned subsidiary, Freedom Bionics:
Yaletown Capital Corporation and its subsidiary, Freedom Bionics, specialise in the design of network-based safety, communications and cognitive assistance applications, products and services. Yaletown Capital Corporation is listed on the TSX-Venture Exchange under the symbol "YCC".
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.